SureTrader
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs > Anavex Life Sciences Corp (AVXL)

ie. at a minimum, he should be

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (3) | Next 10 | Previous | Next
F1ash Member Profile
 
Followed By 30
Posts 3,355
Boards Moderated 1
Alias Born 07/16/14
160x600 placeholder
Annual Report (10-k) "Edgar (US Regulatory)" - 12/11/2017 5:17:35 PM
Anavex Life Sciences Reports Fiscal 2017 Financial Results And Provides Update On Therapeutic Programs "GlobeNewswire Inc." - 12/11/2017 7:00:00 AM
Anavex Life Sciences Reports Newly Published Data on Alzheimer's Disease Research Demonstrate the Neuroprotective Features of... "GlobeNewswire Inc." - 11/21/2017 7:00:00 AM
Anavex Life Sciences to Present at the 5th Annual Mental Health Parity Addiction Equity Act Business Roundtable in Washington... "GlobeNewswire Inc." - 11/8/2017 7:00:00 AM
Anavex Life Sciences Presents New Clinical Data of Investigational Alzheimer’s Disease Treatment ANAVEX®2-73 at 2017 Clini... "GlobeNewswire Inc." - 11/4/2017 3:30:00 PM
Greenbank Cap, Inc. (OTC Pink: GRNBF) Closes Private Placement as Shares Climb "InvestorsHub NewsWire" - 10/30/2017 7:00:00 AM
Anavex Life Sciences Announces Additional Data at The Michael J. Fox Foundation’s Parkinson's Disease Therapeutics Conferen... "GlobeNewswire Inc." - 10/30/2017 7:00:00 AM
Anavex Life Sciences Announces New Data Related to Multiple Sclerosis Presented at 7th ECTRIMS-ACTRIMS Meeting MSPARIS2017 "GlobeNewswire Inc." - 10/27/2017 8:52:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/26/2017 2:50:54 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/24/2017 12:06:59 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/19/2017 6:47:52 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/18/2017 9:47:41 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/16/2017 11:07:52 AM
Anavex Life Sciences Reports PK and PD Data from Phase 2a Trial of ANAVEX®2-73 in Mild-to-Moderate Alzheimer’s Disease Pat... "GlobeNewswire Inc." - 10/12/2017 7:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/6/2017 5:18:01 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/5/2017 5:57:37 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/2/2017 7:53:34 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/29/2017 2:33:03 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/26/2017 3:10:51 PM
Anavex Life Sciences to Present at the Ladenburg Thalmann 2017 Healthcare Conference "GlobeNewswire Inc." - 9/21/2017 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/20/2017 4:51:51 PM
Biotech's Recently Under the Microscope, Analyst Coverage "InvestorsHub NewsWire" - 9/20/2017 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/19/2017 1:59:44 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/14/2017 2:28:25 PM
Alzheimer’s Disease: Cannabis Formulation Shows Promise "NetworkNewsWire" - 9/12/2017 8:45:00 AM
F1ash   Thursday, 10/12/17 09:19:53 PM
Re: seventhwave post# 124382
Post # of 134376 
Quote:
ie. at a minimum, he should be able to escalate dosage on the "ongoing 25" to 50mg in case they were below it and didn't optimally respond, to then determine if observed effect matches Ariana's projections.



If I’m reading and understanding their previous poster correctly that seems very unlikely.

“These results closely reflect the practical course of the study where 25% of the patients remained on their initially allocated dose level of 50 mg while 75% of the total number of patients remained in the 30 mg dose level after five weeks of treatment.


http://www.anavex.com/my_uploads/New-Alzheimers-Drug-ANAVEX-2-73-Phase-2A-Study.pdf

I’ve never seen this discussed here before, but perhaps this is where the “low dose” patients come from?

It’s a bit confusing because apparently patients were on “between 10 and 50 mg and the charts show (low , med and high) concentrations.

Are all of the “low” those that were dropped from the 30 and 50 mg groups? The numbers would make sense if that were the case but, it seems unlikely more patients could be increased to 50 mg due to side effects. (Again, only if I understand the statement from the original poster presentation correctly.)

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (3) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist